Immunic, Inc. (IMUX)Healthcare | Biotechnology | New York, United States | NasdaqCM
14.64 USD
-0.13
(-0.880%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 6:10 a.m. EDT
The investment case for Immunic is currently broken by a catastrophic multi-year price collapse and deteriorating fundamentals. The stock has lost nearly 99.7% of its value over the last nine years, with four consecutive years of negative annual returns, signaling a structural failure in the business model rather than a temporary setback. Fundamentals confirm this distress: the company reports negative earnings, negative free cash flow, and negative returns on both assets and equity. While the balance sheet shows low debt and a healthy current ratio, this liquidity cannot sustain operations indefinitely without capital infusion, which remains uncertain given the lack of analyst coverage and the recent reverse stock split. The options market reflects this pessimism, with heavy put buying suggesting investors are betting on further downside. There is no dividend to provide income, and the statistical forecast offers no relief. This is a speculative vehicle for high-risk tolerance investors only, not a viable long-term holding. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.145640 |
| AutoETS | 0.153269 |
| AutoARIMA | 0.164429 |
| AutoTheta | 0.184215 |
| MSTL_126 | 0.291919 |
Forecast horizon: 60 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.87 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.091 |
| Excess Kurtosis | -0.86 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.278 |
| Market Cap | 199,418,512 |
| Forward P/E | -4.13 |
| Beta | 1.38 |
| Website | https://imux.com |
As of July 11, 2026, 6:10 a.m. EDT: Speculators are aggressively positioning for downside protection, evidenced by massive open interest in deep out-of-the-money puts (strikes at 1.0 and 1.5) compared to negligible call activity. The implied volatility for these protective puts is significantly elevated relative to ATM options, indicating a market consensus expecting a sharp decline rather than a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.7583333 |
| Address1 | 1,200 Avenue of the Americas |
| Address2 | Suite 200 |
| All Time High | 14,080.0 |
| All Time Low | 5.06 |
| Ask | 18.2 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 169,930 |
| Average Daily Volume3 Month | 269,124 |
| Average Volume | 269,124 |
| Average Volume10Days | 169,930 |
| Beta | 1.375 |
| Bid | 10.64 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 11.103 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.64 |
| Current Ratio | 4.92 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 14.87 |
| Day Low | 14.19 |
| Debt To Equity | 0.278 |
| Display Name | Immunic |
| Dividend Date | 1,555,286,400 |
| Earnings Call Timestamp End | 1,730,984,400 |
| Earnings Call Timestamp Start | 1,730,984,400 |
| Earnings Timestamp | 1,786,019,400 |
| Earnings Timestamp End | 1,786,019,400 |
| Earnings Timestamp Start | 1,786,019,400 |
| Ebitda | -109,480,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.121 |
| Enterprise Value | 13,211,141 |
| Eps Current Year | -4.38333 |
| Eps Forward | -3.54625 |
| Eps Trailing Twelve Months | -4.77 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 13.2859 |
| Fifty Day Average Change | 1.3541002 |
| Fifty Day Average Change Percent | 0.1019201 |
| Fifty Two Week Change Percent | 75.833336 |
| Fifty Two Week High | 15.84 |
| Fifty Two Week High Change | -1.1999998 |
| Fifty Two Week High Change Percent | -0.07575756 |
| Fifty Two Week Low | 5.06 |
| Fifty Two Week Low Change | 9.58 |
| Fifty Two Week Low Change Percent | 1.8932806 |
| Fifty Two Week Range | 5.06 - 15.84 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,397,741,400,000 |
| Float Shares | 11,842,010 |
| Forward Eps | -3.54625 |
| Forward P E | -4.1283045 |
| Free Cashflow | -41,392,752 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 95 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00973 |
| Held Percent Institutions | 0.46904 |
| Implied Shares Outstanding | 13,621,483 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,777,248,000 |
| Last Split Factor | 1:10 |
| Long Business Summary | Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York. |
| Long Name | Immunic, Inc. |
| Market | us_market |
| Market Cap | 199,418,512 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_403013221 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -104,287,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 198,465,007 |
| Number Of Analyst Opinions | 9 |
| Open | 14.74 |
| Operating Cashflow | -81,331,000 |
| Operating Margins | 0.0 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 332 255 9818 |
| Pre Market Change | -0.010000229 |
| Pre Market Change Percent | -0.06830757 |
| Pre Market Price | 14.63 |
| Pre Market Time | 1,784,016,062 |
| Previous Close | 14.77 |
| Price Eps Current Year | -3.3399267 |
| Price Hint | 2 |
| Price To Book | 1.3185626 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.874 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.13 |
| Regular Market Change Percent | -0.880163 |
| Regular Market Day High | 14.87 |
| Regular Market Day Low | 14.19 |
| Regular Market Day Range | 14.19 - 14.87 |
| Regular Market Open | 14.74 |
| Regular Market Previous Close | 14.77 |
| Regular Market Price | 14.64 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 251,660 |
| Return On Assets | -0.65181 |
| Return On Equity | -1.4291201 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 13,621,483 |
| Shares Percent Shares Out | 0.1165 |
| Shares Short | 1,587,111 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,764,788 |
| Short Name | Immunic, Inc. |
| Short Percent Of Float | 0.1233 |
| Short Ratio | 7.2 |
| Source Interval | 15 |
| State | NY |
| Symbol | IMUX |
| Target High Price | 85.0 |
| Target Low Price | 19.0 |
| Target Mean Price | 44.66667 |
| Target Median Price | 40.0 |
| Total Cash | 186,628,992 |
| Total Cash Per Share | 13.701 |
| Total Debt | 421,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.77 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 9.691375 |
| Two Hundred Day Average Change | 4.9486256 |
| Two Hundred Day Average Change Percent | 0.5106216 |
| Type Disp | Equity |
| Volume | 251,660 |
| Website | https://imux.com |
| Zip | 10,036 |